Trends in microbiology 2005,13(8):389–397.PubMedCrossRef 5. Sadikot RT, Blackwell TS, Christman JW, Prince AS: Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005,171(11):1209–1223.PubMedCrossRef 6. Alcorn JF, Wright JR: Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J Biol Chem 2004,279(29):30871–30879.PubMedCrossRef 7.
Cowell BA, Twining SS, Hobden JA, Kwong MS, Fleiszig SM: Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of epithelial cells. Microbiology 2003,149(Pt 8):2291–2299.PubMedCrossRef 8. Lau MEK inhibitor GW, Hassett DJ, Ran H, Kong F: The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med 2004,10(12):599–606.PubMedCrossRef
9. Leduc D, Beaufort N, De Bentzmann S, Rousselle JC, Namane A, Chignard M, Pidard D: The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis. Infect Immun 2007,75(8):3848–3858.PubMedCrossRef 10. Matsumoto K: Role of bacterial proteases in pseudomonal and serratial keratitis. Biol Chem 2004,385(11):1007–1016.PubMed 11. Veesenmeyer JL, Hauser AR, Lisboa T, Rello J: Pseudomonas aeruginosa virulence and therapy: evolving translational strategies. Crit Care Med 2009,37(5):1777–1786.PubMedCrossRef 12. Cobb LM, Mychaleckyj JC, Wozniak DJ, Lopez-Boado YS: Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease. J Immunol 2004,173(9):5659–5670.PubMed 13. Fuchs EL, Brutinel ED, Jones AK, Fulcher NB, Urbanowski ML, Yahr TL, LY3009104 nmr Wolfgang MC: The Pseudomonas aeruginosa Vfr regulator controls global virulence factor expression through cyclic AMP-dependent and -independent mechanisms. J Bacteriol 2010,192(14):3553–3564.PubMedCrossRef
14. Smith RS, Wolfgang MC, Lory S: An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia. Infect Immun Reverse transcriptase 2004,72(3):1677–1684.PubMedCrossRef 15. West SE, Sample AK, Runyen-Janecky LJ: The vfr gene product, required for Pseudomonas aeruginosa exotoxin A and protease production, belongs to the cyclic AMP receptor protein family. J Bacteriol 1994,176(24):7532–7542.PubMed 16. Albus AM, Pesci EC, Runyen-Janecky LJ, West SE, Iglewski BH: Vfr controls quorum sensing in Pseudomonas aeruginosa . J Bacteriol 1997,179(12):3928–3935.PubMed 17. Beatson SA, Whitchurch CB, Sargent JL, Levesque RC, Mattick JS: Differential regulation of twitching motility and elastase production by Vfr in Pseudomonas aeruginosa . J Bacteriol 2002,184(13):3605–3613.PubMedCrossRef 18. Kanack KJ, Runyen-Janecky LJ, Ferrell EP, Suh SJ, West SE: Characterization of DNA-binding specificity and analysis of binding sites of the Pseudomonas aeruginosa global regulator, Vfr, a homologue of the Escherichia coli cAMP receptor protein.
No related posts.